Vertex Pharmaceuticals (NDAQ: VRTX) stands today as a top 20 pharma company with over a $100 billion market cap. But this biotech beacon has ridden a bumpy path to its current perch and, along the way ...

Vertex Pharmaceuticals stock was heading for a double-digit gain this year until recent weeks. The company is approaching an important turning point -- one that could set the tone for revenue growth.

Google Cloud this week introduced Vertex AI Agent Builder, a new tool that consolidates Vertex AI Search and Conversation products, enhancing the developer's toolbox for generative AI agent ...